Zymeworks Inc.: Truist Securities raises target price to $35 from $34
ZYME•Truist Securities raised its target price for Zymeworks Inc. to $35 from $34.
Related News
AeroSafe cuts target price to $6.00 from $7.50
ASLE•
Over half of employers pilot or use AI in benefits, Define Ventures and Aon survey finds
AON•
Humacyte secures U.S. patent covering Symvess manufacturing and storage into 2043
HUMA•
Contango Silver & Gold expects 2026 production at lower end of guidance
CTGO•
Innoviz sees strong counter-UAS demand at AUSA 2026
INVZ•